REFERENCES
- Suda, T., Takahashi, N., Martin, T.J. (1992). Modulation of osteoclast differentiation. Endocr. Rev. 13(1): 66–80. [PUBMED], [INFOTRIEVE], [CSA]
- Suda, T., Udagawa, N., Takahashi, N. (1996). Osteoclast generation, in Principles of Bone Biology, 2nd ed., J.P. Bilizikian, L.G. Raisz, G.A. Rodan, Eds., Academic Press: San Diego, CA, pp. 87–102.
- Athanasou, N.A. (1996). Cellular biology of bone-resorbing cells. J Bone Joint Surg Am. 78(7): 1096–1122. [PUBMED], [INFOTRIEVE], [CSA]
- Fujikawa, Y., Quinn, J.M.W., Sabokbar, A., McGee, J.O.D., Athanasou, N.A. (1996). The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 137(9): 4058–4060. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Khosla, S. (2001). Minireview: the OPG/RANKL/RANK system. Endocrinology 142(12): 5050–5055. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lacey, D.L., Timms, E., Tan, H.L., Kelley, M.J., Dunstan, C.R., Burgess, T., Elliot, R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, YX., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J., Boyle, W.J. (1998). Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93(2): 165–176. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamuguchi, K., Kuiyama, M., Kanno, T., Murakami, A., Tsuda, E., Morinaga, T., Higashio, K. (1998). Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139(3): 1329–1337. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gravallese, E.M., Manning, C., Tsay, A., Naito, A., Pan, C., Amento, E., Goldring, S.R. (2000). Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis & Rheumatism 43(2): 250–258. [INFOTRIEVE], [CSA], [CROSSREF]
- Hofbauer, L.C., Khosla, D., Dunston, C.R., Lacey, D.L., Boyle, W.J., Riggs, B.L. (2000). The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Mineral Res. 15(1): 2–12. [CSA]
- Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., Yasuda, H., Morinaga, T., Higashinio, K., Martin, TJ., Suda, T. (2000). Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of ODF/RANKL-RANK interaction. J Exp Med. 191(2): 275–286. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Fuller, K., Murphy, C., Kirstein, B., Fox, S.W., Chambers, T.J. (2002). TNF-α potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 143(3): 1108–118. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jimi, E., Nakamura, I., Duong, L.T., Ikebe, T., Takahashi, N., Rodan, G.A., Suda, T. (1999). Interleukin-1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblast/stromal cells. Exp Cell Res. 247(1): 84–93. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Garcia, C., Boyce, B.F., Gilles, J., Dallas, M., Qiao, M., Mundy, G.R., Bonewald L.F. (1996). Leukotriene B4 stimulates osteoclastic bone resorption both in vitro and in vivo. J Bone Miner Res. 11(11): 1619–1627. [PUBMED], [INFOTRIEVE], [CSA]
- Flynn, M.A., Qiao, M., Garcia, C., Dallas, M., Bonewald, L.F. (1999). Avian osteoclast cells are stimulated to resorb calcified matrices by and pocess receptors for leukotriene B4. Calcif Tissue Int. 64(2): 154–159. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mikin, C. (1982). Bone acid phosphates: Tartrate-resistant acid phosphates as a marker of osteoclast function. Calcif Tissue Int. 34(3): 285–290. [CSA]
- Crooks, S.W., Stockley, R.A. Molecules in focus: Leukotriene B4. (1998). Int J Biochem Cell Biol. 30(2): 173–178. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Penrose, J.F., Austen, K.F. (1999). The biochemical, molecular, and genomic aspects of leukotriene C4 synthase. Proc Assoc Am Physicians 111(6): 537–546. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Los, M., Schenk, H., Hexel, K., Baeuerle, P.A., Droge, W., Schulze-Osthoff, K. (1995). Il-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipooxygenase. EMBO J 14(15): 3731–3740. [PUBMED], [INFOTRIEVE], [CSA]
- Gok, S., Ulker, S., Huseyinov, A., Hatip, F.B., Cinar, M.G., Evinc, A. (2000). Role of leukotrienes on coronary vasoconstriction in isolated hearts of arthritis rats: effect of in vivo treatment with CI-986, a dual inhibitor of cyclooxygenase and lipoxygenase. Pharmacology 60(1): 41–46. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ahmadzadeh, N., Shingu, M., Nobunaga, M., Tawara, T. (1991). Relationship between leukotriene B4 and immunological parameters in rheumatoid synovial fluids. Inflammation 15(6): 497–503. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Roodman, G.D. (1999). Cell biology of the osteoclast. Exp Hematol. 27(8): 1229–1241. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Quinn, J.M., Elliot, J., Gillespie, M.T., Martin, T.J. (1998). A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and osteoclast formation. Endocrinology 139(10): 4424–4427. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Udagawa, N., Takahashi, N., Akatsu, T., Tanaka, H., Sasaki, T., Nishihara, T., Koga, T., Suda, T. (1990). Origin of osteoclasts: Mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenviroment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci U.S.A. 87(18): 7260–7264. [PUBMED], [INFOTRIEVE], [CSA]
- Kudo, O., Sabokbar, A., Pocock, A., Itonaga, I., Fujikawa, Y., Athanasou, NA. (2003). Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 32(1): 1–7. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Quinn, J.M.W., Neale, S., Fujikawa, Y., McGee, J.O.D., Athanasou, N.A. (1998). Human osteoclast formation from blood monocytes, peritoneal macrophages, and bone marrow cells. Calcif Tissue Int. 62(6): 527–531. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ibbotson, K.J., Roodman, G.D., McManus, L.M., Mundy, G.R. (1984). Identification and characterization of osteoclast-like cells and their progenitors in culture of feline marrow mononuclear cells. J Cell Biol. 99(2): 474. [CSA], [CROSSREF]
- Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., Shimizu, T. (1997). A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 387(6633): 620–624. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yokomizo, T., Kato, K., Terawaki, K., Izumi, T., Shimizu, T. (2000). A second leukotriene B4 receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J Exp Med. 192(3): 421–432. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Yokomizo, T., Izumi, T., Shimizu, T. (2001). Co-expression of two LTB4 receptors in human mononuclear cells. Life Sci. 68(19–20): 2207–2212. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]